Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease

Fig. 7

The expression of E-cadherin and α-SMA following UUO and MVs/EPO-MVs administration. Western blot analysis was used to detect the protein expression of E-cadherin and a-SMA as a percentage of tubulin in mice exposed to control and MV/EPO-MV administration at 7 and 14 days. All of the experiments were repeated three times (n = 3). *p < 0.01, 7 day UUO group versus control group or 14 day UUO group versus control group, $ p < 0.01, 7 day UUO + MV group versus UUO group or 14 day UUO + MV group versus UUO group, # p < 0.05, 7 day UUO + EPO-MV group versus UUO + MV group or 14 day UUO + EPO-MV group versus UUO + MV group. EPO erythropoietin MVs microvesicles UUO unilateral ureteral obstruction α-SMA α-smooth muscle actin

Back to article page